Correlation Between Clal Biotechnology and Direct Capital

Can any of the company-specific risk be diversified away by investing in both Clal Biotechnology and Direct Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Clal Biotechnology and Direct Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Clal Biotechnology Industries and Direct Capital Investments, you can compare the effects of market volatilities on Clal Biotechnology and Direct Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Clal Biotechnology with a short position of Direct Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of Clal Biotechnology and Direct Capital.

Diversification Opportunities for Clal Biotechnology and Direct Capital

0.75

Correlation Coefficient

Clal Biotechnology  Direct Capital

Poor diversification

The 3 months correlation between Clal and Direct is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Clal Biotechnology Industries and Direct Capital Investments in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Direct Capital Inves and Clal Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Clal Biotechnology Industries are associated (or correlated) with Direct Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Direct Capital Inves has no effect on the direction of Clal Biotechnology i.e., Clal Biotechnology and Direct Capital go up and down completely randomly.

Pair Corralation between Clal Biotechnology and Direct Capital

Assuming the 90 days trading horizon Clal Biotechnology Industries is expected to generate 0.28 times more return on investment than Direct Capital. However, Clal Biotechnology Industries is 3.59 times less risky than Direct Capital. It trades about 0.29 of its potential returns per unit of risk. Direct Capital Investments is currently generating about -0.18 per unit of risk. If you would invest  3,400  in Clal Biotechnology Industries on October 21, 2024 and sell it today you would earn a total of  340.00  from holding Clal Biotechnology Industries or generate 10.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Clal Biotechnology Industries  vs.  Direct Capital Investments

Clal Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Clal Biotechnology Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Direct Capital Inves

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Direct Capital Investments has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Clal Biotechnology and Direct Capital

The main advantage of trading using opposite Clal Biotechnology and Direct Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Clal Biotechnology position performs unexpectedly, Direct Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Direct Capital will offset losses from the drop in Direct Capital's long position.

The idea behind Clal Biotechnology Industries and Direct Capital Investments pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.